Highlights from PTCOG 2008
OncoLink reporters provide up-to-date coverage of the Particle Therapy Cooperative Group (PTCOG) 47 Conference from Jacksonville, Florida, May 19-24, 2008.
15 years of Proton Radiosurgery Experience at the Ithemba Labs, Long Term Results for AVM’s, Meningiomas, and Acoustic Neuromas Analysis of Visual Loss Due to Radiation-Induced Optic Neuropathy After Particle Therapy for Head and Neck and Skull Base Tumors Adjacent to Optic Nerves. Carbon Ion Radiotherapy for Skull Base and Paracervical Chordomas Carbon Ion Radiotherapy in Germany: Update on the Clinical Results from 394 patients Treated at the University of Heidelberg and on the Future Perspectives at the Heidelberg Ion Therapy Center (HIT) Changes in the Rectal Volume and Prostate Localization with Placement of a Rectum Emptying Tube Clinical Trials in Particle Therapy Comparison of Proton and Photon Radiation Treatment Plans for the Adjuvant Treatment of Pancreatic Cancer Including Comprehensive Nodal Radiation Craniopharyngioma: Early Response Evaluation of Patients Treated with Protons at the Midwest Proton Radiotherapy Institute in Bloomington, Indiana. Designing a Multileaf Collimator for Proton Therapy Does Proton Beam Radiotherapy (PBT) Reduce Treatment Related Pneumonitis (TRP) Compared to Intensity Modulated Radiation Therapy (IMRT) in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Concurrent Chemotherapy? Dosimetric Advantages of Proton Simultaneous In-Field Boost (PSIB) Technique for Treating Lung Cancer Effectiveness of Rectal Balloon as an Internal Immobilization Device for Proton Therapy of Prostate Cancer Efficacy and Safety of Spot Scanning Proton Radiation Therapy for Skull Base Tumors: First Long Term Report of the PSI Experience Head and Neck Cancer and Proton Therapy Images from PTCOG 2008 Lung Cancer and Proton Therapy Panel Discussion: Randomized Trials vs. Prospective Registry Particle and Proton Radiotherapy in Treatment of Pediatric Oncology Patients Pelvic Proton Radiotherapy for High-Risk Prostate Cancer Reduction of Bone Marrow Suppression for Patients with Stage III NSCLC Treated by Protons and Chemotherapy Compared with IMRT and Chemotherapy Use of Particle Therapy in Treatment of Sarcomas